A Huaxian Formula Nanoformulation Confers Protection Against Acute Radiation‐Induced Lung Injury by Targeting Ferroptosis
Advanced Science · 2026-11 · 13 (62)
DOI: 10.1002/advs.77472 ↗At a glance
Journal article in Advanced Science, published online on 2026-08-29. Written by Li Quan and 11 co-authors. Institution: Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Si…. Major MEDLINE topics: Ferroptosis, Drugs, Chinese Herbal, Acute Lung Injury. 61 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundamental Research Funds for the Central Universities, Health Commission of Sichuan Province, Scientific Research Project of Sichuan Medical Association.
Abstract (original language)
Acute radiation‐induced lung injury (RILI) remains a major dose‐limiting complication of thoracic radiotherapy with limited therapeutic options. Here, we develop an inhalable nanoformulation of the traditional Chinese medicine Huaxian Formula (NHXF) with favorable physicochemical stability and enhanced pulmonary delivery properties. In vitro and in vivo studies demonstrate that NHXF attenuates radiation‐induced alveolar epithelial injury, accompanied by reductions in oxidative stress and apoptosis. NHXF also suppresses secondary inflammatory responses, as evidenced by decreased pro‐inflammatory cytokine production and neutrophil infiltration, which may contribute to its protective effects against acute RILI. Importantly, NHXF displays a favorable safety profile throughout treatment. Transcriptomic analysis highlights ferroptosis‐related pathways associated with NHXF‐mediated protection. Our findings indicate that NHXF treatment is associated with the attenuation of ferroptosis‐related alterations in iron homeostasis and lipid peroxidation. Pharmacological activation of ferroptosis significantly diminishes the protective effects of NHXF against radiation‐induced injury, further supporting a functional contribution of ferroptosis modulation to NHXF‐mediated protection, while acknowledging that additional direct mechanistic evidence is warranted to establish causal dependency. Collectively, these findings support NHXF as a potential inhalable nanotherapeutic for acute RILI and highlight pulmonary delivery of nanoformulated traditional Chinese medicine combined with ferroptosis modulation as a promising strategy for RILI management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Center, Sichuan Cancer Hospital & Institute, Affiliated C…
- School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
ORCID profiles: Shunlian Fu, Meihua Chen
Funding
- Fundamental Research Funds for the Central Universities
- Health Commission of Sichuan Province
- Scientific Research Project of Sichuan Medical Association
- Transformation Foundation of Tianfu Jincheng Laboratory
Cite
APA
Quan, L., Chen, J., Chen, X., Fang, Z., Mi, Y., Zou, P., Fu, S., Li, H., Xu, K., Lin, B., Lang, J., & Chen, M. (2026). A Huaxian Formula Nanoformulation Confers Protection Against Acute Radiation‐Induced Lung Injury by Targeting Ferroptosis. Advanced Science, 13(62). https://doi.org/10.1002/advs.77472
Vancouver
Quan L, Chen J, Chen X, Fang Z, Mi Y, Zou P, et al. A Huaxian Formula Nanoformulation Confers Protection Against Acute Radiation‐Induced Lung Injury by Targeting Ferroptosis. Advanced Science. 2026;13(62). doi:10.1002/advs.77472
BibTeX
@article{Quan2026,
author = {Quan, Li and Chen, Junyang and Chen, Xingmin and Fang, Zengyi and Mi, Yuanzhen and Zou, Pingjin and Fu, Shunlian and Li, Huakang and Xu, Ke and Lin, Bing and Lang, Jinyi and Chen, Meihua},
title = {A Huaxian Formula Nanoformulation Confers Protection Against Acute Radiation‐Induced Lung Injury by Targeting Ferroptosis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {62},
doi = {10.1002/advs.77472}
}
EUVIMED